LRP4 mutations promote tumour progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinoma.
Sun R, Liu K, Pan S, Ye Y, Li N, Chen S, Cui X, Zhang Y, Chen L, Pan J, Hu Z, Luo C, Fan J, Zhou Z, Zhou S, Zhou J.
Sun R, et al. Among authors: pan j.
Hepatology. 2024 Dec 24. doi: 10.1097/HEP.0000000000001212. Online ahead of print.
Hepatology. 2024.
PMID: 39723987